Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study

Conclusions:
In the SMILE-4 study the propensity analysis confirmed the efficacy of zofenopril in the prevention of long-term cardiovascular outcomes irrespective of the cardiovascular risk profile of post-AMI patients.

Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - October 4, 2016 Category: Biomedical Science Authors: Borghi, C., Omboni, S., Novo, S., Vinereanu, D., Ambrosio, G., Ambrosioni, E., on behalf of the SMILE-4 Working Party Tags: Original Article Source Type: research